Doma perpetual sends letter to board of directors of pacira biosciences to immediately accelerate and increase its share buyback program to enhance return to shareholders

Believes pacira's cash balance of $400 million, roughly 59% of its market capitalization, is grossly inefficient. emphasizes the current stock price offers an extraordinary opportunity to create meaningful return for shareholders miami , sept.
DOMA Ratings Summary
DOMA Quant Ranking